BioCentury
ARTICLE | Financial News

Vivo closes eighth fund with $750M

March 19, 2015 2:04 AM UTC

Vivo Capital said it closed Vivo Capital Fund VIII with $750 million. Vivo intends to invest the fund in late-stage pharma and medical device companies in the U.S. and in revenue-stage healthcare companies in greater China. Vivo disclosed in an SEC filing in December that it had raised $427.7 million for the fund (see BioCentury, Jan. 5). ...